NCT03989401 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Hindi AMK, Seston EM, Bell D, Steinke D, Willis S, Schafheutle EI
Independent prescribing in primary care: A survey of patients', prescribers' and colleagues' perceptions and experiences. Health Soc Care Community. 2019 Jul;27(4):e459-e470. doi: 10.1111/
Jacob C, Sanchez-Vazquez A, Ivory C
Clinicians' Role in the Adoption of an Oncology Decision Support App in Europe and Its Implications for Organizational Practices: Qualitative Case Study. JMIR Mhealth Uhealth. 2019 May 3;7(5):e13555. doi: 10.2196/13555

If Muti-media Health Education Reduces the Workload of Nurses Without Affecting Patient's Satisfaction:a Perspective Randomized Controlled Trial

Clinical trial NCT03989401 - References